Results 81 to 90 of about 3,251 (194)
Portal circulation and portal hypertension. [PDF]
During the last 25 years, there have been important developments in visualising the portal vein, in examining its contents, and in measuring the pressure of blood flowing within it. Radiologists have set the scene and now is the time of the scanner.
openaire +3 more sources
Left-Sided Portal Hypertension: A Case Series
Left-sided portal hypertension is rarely found, but this condition may cause gastrointestinal tract bleeding and can be life-threatening. The exact incidence of left-sided portal hypertension is unknown as it is rarely found, approximately 1-5%, and most
Guntur Darmawan+2 more
doaj
Introduction We report for the first time a unique case of VACTERL (vertebral anomalies, anal atresia or imperforate anus, cardiac anomalies, tracheoesophageal fistula, renal and limb defect) spectrum associated with portal hypertension.
Losa Ignatius, Bhurtel Dilli
doaj +1 more source
Portal hypertension in children [PDF]
Recommended approaches to the management of portal hypertension and esophageal varices in children continue to rely on expert opinion, low‐quality pediatric studies, and the extrapolation of the results of studies in adult populations. There is a pressing need for high‐quality pediatric studies, and expert panels recently have itemized the priorities ...
openaire +3 more sources
FIGO guideline on liver disease and pregnancy
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana+24 more
wiley +1 more source
Failure of Splenectomy to Ameliorate Portal Hypertension in Myeloproliferative Disorders
The correct treatment of portal hypertension associated with myeloproliferative disorders remains uncertain. Splenectomy has been advocated by some to eliminate the forward flow component of the portal hypertension and thus reduce portal pressure.
Samuel S Lee+4 more
doaj +1 more source
The effect of elexacaftor–tezacaftor–ivacaftor on liver stiffness in children with cystic fibrosis
Abstract Objectives Cystic fibrosis hepato‐biliary involvement (CFHBI) is a common comorbidity in patients with CF and is associated with increased morbidity and mortality. The effect of the new and highly potent CF transmembrane conductance regulator modulator therapy, elexacaftor–tezacaftor–ivacaftor (ETI), on CFHBI, is still unclear.
Stefanie Diemer+4 more
wiley +1 more source
The role of the liver histological and necroinflammatory activity in the development of portal hypertension syndrome [PDF]
Background. Liver cirrhosis is the most often cause of the portal hypertension syndrome development, though structural and morphological liver remodeling usually begins on the stage of chronic hepatitis.
Dzyubanovsky I.Ya.+4 more
doaj
Abstract Graft versus host disease (GVHD) is a complication that frequently occurs after haematopoietic stem cell transplantation and concerns many children in paediatric haematology‐oncology and bone marrow transplantation departments. It can affect various organs, with the skin, gastrointestinal tract and liver being the most commonly involved.
Marina Vincent+12 more
wiley +1 more source